Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
46.3 EUR | +3.26% | +6.63% | -4.81% |
Apr. 24 | COVIVIO : Invest Securities remains Buy after sales release | CF |
Apr. 24 | Covivio: stable revenues in Q1 | CF |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The company appears to be poorly valued given its net asset value.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- This company will be of major interest to investors in search of a high dividend stock.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- The opinion of analysts covering the stock has improved over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- One of the major weak points of the company is its financial situation.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 45.27 times its estimated earnings per share for the ongoing year.
- Based on current prices, the company has particularly high valuation levels.
- For the past year, analysts have significantly revised downwards their profit estimates.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Commercial REITs
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-4.81% | 4.81B | A- | ||
-6.30% | 46.33B | A- | ||
-7.47% | 20.51B | A- | ||
-4.15% | 12.94B | A- | ||
+16.38% | 11.45B | A | ||
-4.85% | 9.75B | B+ | ||
-0.47% | 8.51B | A- | ||
-14.19% | 8.43B | B- | ||
+1.46% | 7.6B | A- | ||
-16.19% | 5.69B | A |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- COV Stock
- Ratings Covivio